In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods

被引：71

作者：

Cercenado, Emilia ^{[1
]}

Marin, Mercedes ^{[1
]}

Sanchez-Martinez, Monica ^{[1
]}

Cuevas, Oscar ^{[1
]}

Martinez-Alarcon, Jose ^{[1
]}

Bouza, Emilio ^{[1
]}

机构：

[1] Univ Complutense Madrid, Hosp Gen Gregorio Maranon, Serv Microbiol Clin & Enfermedade Infecciosas, Madrid 28007, Spain

来源：

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2007年 / 51卷 / 03期

关键词：

D O I：

10.1128/AAC.01102-06

中图分类号：

Q93 [微生物学];

学科分类号：

071005 [微生物学]; 100705 [微生物与生化药学];

摘要：

The in vitro activities of tigecycline and other antimicrobials against 51 isolates of Nocardia spp. were evaluated. MIC,os and MIC ranges were as follows: tigecycline, 4 and <= 0.06 to 8 mg/liter, respectively; minocycline, 2 and <= 0.06 to 2 mg/liter, respectively; linezolid, 1 and <= 0.06 to 2 mg/liter, respectively; moxifloxacin, 2 and <= 0.06 to > 64 mg/liter, respectively; ertapenem, 32 and <= 0.06-> 64 mg/liter, respectively; imipenem, 2 and <= 0.06 to > 64 mg/liter, respectively; meropenem, 8 and <= 0.06 to > 64 mg/liter, respectively; amikacin, 1 and <= 0.06 to 32 mg/liter, respectively; and trimethoprim-sulfamethoxazole, 1/19 and <= 0.5/9.5 to > 2/38 mg/liter, respectively.

引用

页码：1102 / 1104

页数：3

共 21 条

[1]

Comparison of agar dilution, broth microdilution, disk diffusion, E-test, and BACTEC radiometric methods for antimicrobial susceptibility testing of clinical isolates of the Nocardia asteroides complex [J].